Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apyx Medical CorpAPYX · Entity 6609 | Sr. V.P. of Operations | June 11, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apyx Medical Corp
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Option to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.65 · Expires 2036-06-11 | Direct | 63,392 |
Reported balance
After 2026-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 63,392 · Balance 63,392 F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 15, 2026 23:00 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 63,392 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001493152-26-028765 · ownership.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,392 Underlying: Common Stock · 63,392 shares Expires 2036-06-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:27 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock option (right to buy) · Derivative | 37,000 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001493152-26-010632 · ownership.xml · derivative · entry 2 CITRONOWICZ MOSHE · CIK 0001280851 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2036-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On March 15, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 37,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:27 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 37,000 | $1.80 | $66,600.00 |
DisclosureSEC source: 0001493152-26-010632 · ownership.xml · nonDerivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:31 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 36,000 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001641172-25-011473 · ownership.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2035-05-15 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:06 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 36,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001493152-25-002762 · ownership.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2035-01-15 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 21:05 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 72,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001493152-24-002059 · ownership.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 72,000 shares Expires 2034-01-10 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 21:17 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 72,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0000719135-23-000005 · wf-form4_167364463889129.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2033-01-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 15:56 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 30,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0000719135-22-000055 · wf-form4_165764139992819.xml · derivative · entry 2 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2022-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reporting Person was granted a stock option that vested and became exercisable over 5 years at a rate of 20% of the option on the anniversary date of each succeeding year. Read SEC document |
| July 11, 2022 Filed Jul 12, 2022 15:56 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 30,000 | $2.54 | $76,200.00 |
DisclosureSEC source: 0000719135-22-000055 · wf-form4_165764139992819.xml · nonDerivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2022 Filed Feb 1, 2022 15:37 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 72,000 | $0.00 Strike: $10.96 | $0.00 |
DisclosureSEC source: 0000719135-22-000010 · wf-form4_164372986171290.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2032-01-19 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 29, 2021 Filed Feb 10, 2021 15:13 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 36,000 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0000719135-21-000012 · wf-form4_161296999537077.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2031-01-29 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 15, 2020 Filed Jan 22, 2020 22:16 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 72,000 | $0.00 Strike: $8.18 | $0.00 |
DisclosureSEC source: 0000719135-20-000007 · wf-form4_157973135780945.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2030-01-15 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| January 09, 2019 Filed Feb 12, 2019 00:11 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 72,000 | $0.00 Strike: $7.91 | $0.00 |
DisclosureSEC source: 0000719135-19-000010 · wf-form4_154993024872488.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2029-01-09 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant. Read SEC document |
| May 01, 2017 Filed Sep 27, 2017 13:18 UTC | Apyx Medical Corp BVX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 70,000 | $0.00 Strike: $3.23 | $0.00 |
DisclosureSEC source: 0000719135-17-000057 · wf-form4_150651830246955.xml · derivative · entry 1 CITRONOWICZ MOSHE · CIK 0001280851 · Sr. V.P. of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2027-04-30 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a forty-eight (48) month period and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.